vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and EMERSON RADIO CORP (MSN). Click either name above to swap in a different company.
EMERSON RADIO CORP is the larger business by last-quarter revenue ($1.9M vs $1.2M, roughly 1.6× Lucid Diagnostics Inc.). EMERSON RADIO CORP runs the higher net margin — -36.7% vs -858.5%, a 821.8% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -52.8%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -7.3%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.
LUCD vs MSN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.2M | $1.9M |
| Net Profit | $-10.4M | $-694.0K |
| Gross Margin | — | 10.9% |
| Operating Margin | -971.0% | -43.7% |
| Net Margin | -858.5% | -36.7% |
| Revenue YoY | 3.3% | -52.8% |
| Net Profit YoY | 16.0% | -31.7% |
| EPS (diluted) | $-0.10 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.9M | ||
| Q3 25 | $1.2M | $1.2M | ||
| Q2 25 | $1.2M | $1.7M | ||
| Q1 25 | $828.0K | $1.8M | ||
| Q4 24 | $1.2M | $4.0M | ||
| Q3 24 | $1.2M | $2.7M | ||
| Q2 24 | $976.0K | $2.2M | ||
| Q1 24 | $1.0M | $2.2M |
| Q4 25 | — | $-694.0K | ||
| Q3 25 | $-10.4M | $-1.0M | ||
| Q2 25 | $-4.4M | $-1.1M | ||
| Q1 25 | $-26.9M | $-2.4M | ||
| Q4 24 | $-11.5M | $-527.0K | ||
| Q3 24 | $-12.4M | $-881.0K | ||
| Q2 24 | $-11.0M | $-962.0K | ||
| Q1 24 | $-10.6M | $-883.0K |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | -0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 12.3% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | — | -43.7% | ||
| Q3 25 | -971.0% | -98.4% | ||
| Q2 25 | -978.8% | -78.1% | ||
| Q1 25 | -1508.1% | -137.8% | ||
| Q4 24 | -1033.8% | -18.3% | ||
| Q3 24 | -997.8% | -40.8% | ||
| Q2 24 | -1146.7% | -55.6% | ||
| Q1 24 | -1078.1% | -52.2% |
| Q4 25 | — | -36.7% | ||
| Q3 25 | -858.5% | -85.8% | ||
| Q2 25 | -381.7% | -68.1% | ||
| Q1 25 | -3249.8% | -127.9% | ||
| Q4 24 | -964.2% | -13.2% | ||
| Q3 24 | -1055.5% | -32.2% | ||
| Q2 24 | -1127.6% | -43.8% | ||
| Q1 24 | -1060.1% | -40.1% |
| Q4 25 | — | $-0.03 | ||
| Q3 25 | $-0.10 | $-0.05 | ||
| Q2 25 | $-0.08 | $-0.05 | ||
| Q1 25 | $-0.52 | $-0.10 | ||
| Q4 24 | $-0.17 | $-0.03 | ||
| Q3 24 | $-0.25 | $-0.04 | ||
| Q2 24 | $-0.23 | $-0.05 | ||
| Q1 24 | $-0.40 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $13.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $18.6M |
| Total Assets | $53.2M | $20.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.3M | ||
| Q3 25 | $47.3M | $13.5M | ||
| Q2 25 | $31.1M | $15.5M | ||
| Q1 25 | $25.2M | $16.1M | ||
| Q4 24 | $22.4M | $16.4M | ||
| Q3 24 | $14.5M | $16.7M | ||
| Q2 24 | $24.9M | $18.9M | ||
| Q1 24 | $24.8M | $19.9M |
| Q4 25 | — | $18.6M | ||
| Q3 25 | $25.8M | $19.3M | ||
| Q2 25 | $7.9M | $20.4M | ||
| Q1 25 | $-5.4M | $21.5M | ||
| Q4 24 | $5.4M | $23.9M | ||
| Q3 24 | $6.3M | $24.4M | ||
| Q2 24 | $16.0M | $25.3M | ||
| Q1 24 | $11.9M | $26.2M |
| Q4 25 | — | $20.1M | ||
| Q3 25 | $53.2M | $20.7M | ||
| Q2 25 | $38.7M | $23.3M | ||
| Q1 25 | $32.8M | $23.5M | ||
| Q4 24 | $30.7M | $26.4M | ||
| Q3 24 | $22.6M | $26.6M | ||
| Q2 24 | $34.1M | $28.5M | ||
| Q1 24 | $32.0M | $29.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-228.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-228.0K | ||
| Q3 25 | $-10.9M | $-2.0M | ||
| Q2 25 | $-10.5M | $-514.0K | ||
| Q1 25 | $-12.5M | $-391.0K | ||
| Q4 24 | $-9.9M | $-293.0K | ||
| Q3 24 | $-10.2M | $-2.1M | ||
| Q2 24 | $-11.5M | $-840.0K | ||
| Q1 24 | $-12.6M | $-2.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-301.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-2.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -7.5% | ||
| Q3 24 | — | -77.8% | ||
| Q2 24 | — | -46.4% | ||
| Q1 24 | — | -102.3% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCD
Segment breakdown not available.
MSN
| Products | $1.8M | 95% |
| Other | $87.0K | 5% |